Patents by Inventor Ping Cao
Ping Cao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11950484Abstract: A display panel includes a display layer, a photosensitive layer and an infrared mask. The display layer is configured to display an image, the display layer has light-transmitting portions, and the light-transmitting portions are configured to transmit infrared light. The photosensitive layer is disposed on a side of the display layer. The infrared mask is disposed on a side of the photosensitive layer proximate to the display layer, the infrared mask has hollowed-out regions, the hollowed-out regions are configured to make the infrared mask have a preset pattern, and a region in the infrared mask except the hollowed-out regions is configured to prevent transmission of the infrared light. The photosensitive layer is configured to receive infrared light passing though the hollowed-out regions and the light-transmitting portions, and convert the infrared light into an image signal.Type: GrantFiled: July 23, 2020Date of Patent: April 2, 2024Assignee: BOE TECHNOLOGY GROUP CO., LTD.Inventors: Pengpeng Wang, Haisheng Wang, Xiaoliang Ding, Yangbing Li, Xueyou Cao, Ping Zhang, Likai Deng, Yubo Wang
-
Publication number: 20240082197Abstract: The present invention relates to the delivery method of Omega-3's and nutritional supplements for the human diet used to aid mental and visual development of human embryos as well as enhance visual acuity and mental fitness in humans. The invention contains vitamins, minerals, and microencapsulated fish oil powder containing DHA and EPA.Type: ApplicationFiled: September 18, 2023Publication date: March 14, 2024Inventors: Thuong Cao Do, Ping Yang
-
Publication number: 20240065445Abstract: The present application relates to the technical field of sofa, and in particular to a compact sofa frame structure, including a base frame and a slidable frame. The base frame is provided with an adjusting assembly. The adjusting assembly includes a driving rod and a driven rod; in which the driving rod and the driven rod are both rotatably connected at one end thereof on the base frame and rotatably connected to the backrest at the other end thereof; a linkage rod rotatably connected on the driving rod; the frame is provided with a driving assembly configured to drive a leg rest rotatably connected on the slidable frame to rotate; the slidable frame is provided with a fixing rod configured to limit the leg rest.Type: ApplicationFiled: May 26, 2023Publication date: February 29, 2024Inventors: Yuanfeng FENG, Jizhong CAO, Jundong GAO, Ping WANG
-
Patent number: 11895522Abstract: A method includes: A first device sends a first signal to a second device, where the first signal includes a first transmit signal and a first pilot signal; the first device obtains a second signal, where the second signal includes a first self-interference signal, a second pilot signal, and a second receive signal from the second device; the first device extracts jitter information of the first self-interference signal based on the first pilot signal and the second pilot signal; the first device reconstructs a self-interference signal based on the first transmit signal and the jitter information of the first self-interference signal, to obtain a cancellation signal of the first self-interference signal; and the first device cancels the first self-interference signal from the second receive signal based on the cancellation signal of the first self-interference signal.Type: GrantFiled: May 6, 2021Date of Patent: February 6, 2024Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Meng Cai, Kun Li, Jiantao Ma, Ping Cao, Hongli Jiang
-
Publication number: 20230286904Abstract: Disclosed herein are synthesis and use of covalent inhibitors selective for Transcriptional Enhancer Factor TEF-1 (TEAD1), which can be used for treatment of cancers such as glioblastoma, gastric cancer, colorectal cancer, pancreatic ductal adenocarcinoma (PDAC), and malignant pleural mesothelioma (MPM). Further disclosed herein are pharmaceutical compositions including the TEAD1 inhibitor and methods of treating cancers using the same.Type: ApplicationFiled: July 2, 2021Publication date: September 14, 2023Inventors: Chao ZHANG, Michael J. BISHOP, Hang CHEN, Ping CAO
-
Patent number: 11740672Abstract: A multiport USB-PD adaptor including a flyback-converter, a USB controller including a USB-PD subsystem and buck-controller, and multiple buck and bypass-circuits, and methods for operating the same are provided. Generally, the adaptor is operated in a buck-bypass-mode, in which at least one buck-circuit is bypassed and the flyback-converter is operated to generate an input voltage (VIN) to the buck-circuits equal to a requested output voltage (VOUT_C), which is then coupled directly to the associated port. Buck-circuits coupled to other active ports can also be bypassed if the requested VOUT_Cs are the same, or the buck-circuits operated to provide another VOUT_C. If a bypass-circuit unavailable, the adaptor is operated in a variable-buck-input-mode by determining a highest VOUT_C requested on any port and setting VIN to a sum of the highest VOUT_C and an offset voltage. Buck-circuits coupled to active ports are then operated to provide the requested output voltages.Type: GrantFiled: July 28, 2021Date of Patent: August 29, 2023Assignee: Cypress Semiconductor CorporationInventors: Chuan-yu Lin, Jen-Hui Cheng, Hua-ping Cao, Yong-shuang Zhu, Hsiang-Nien Kuo
-
Publication number: 20220350388Abstract: A multiport USB-PD adaptor including a flyback-converter, a USB controller including a USB-PD subsystem and buck-controller, and multiple buck and bypass-circuits, and methods for operating the same are provided. Generally, the adaptor is operated in a buck-bypass-mode, in which at least one buck-circuit is bypassed and the flyback-converter is operated to generate an input voltage (VIN) to the buck-circuits equal to a requested output voltage (VOUT_C), which is then coupled directly to the associated port. Buck-circuits coupled to other active ports can also be bypassed if the requested VOUT_Cs are the same, or the buck-circuits operated to provide another VOUT_C. If a bypass-circuit unavailable, the adaptor is operated in a variable-buck-input-mode by determining a highest VOUT_C requested on any port and setting VIN to a sum of the highest VOUT_C and an offset voltage. Buck-circuits coupled to active ports are then operated to provide the requested output voltages.Type: ApplicationFiled: July 28, 2021Publication date: November 3, 2022Applicant: Cypress Semiconductor CorporationInventors: Chuan-yu Lin, Jen-Hui Cheng, Hua-ping Cao, Yong-shuang Zhu, Hsiang-Nien Kuo
-
Publication number: 20220288069Abstract: The present disclosure provides compounds and compositions thereof which are useful as inhibitors of tyrosine kinase and which exhibit desirable characteristics for the same. Further disclosed herein are methods of treating cancer using these tyrosine kinase inhibitor compounds.Type: ApplicationFiled: July 17, 2020Publication date: September 15, 2022Inventors: Chao Zhang, Ping Cao, Michael J. Bishop
-
Publication number: 20220276253Abstract: The present disclosure provides a profiling method based on comparative mass spectrometry analysis for identifying and quantifying the covalent interactions of electrophilic compounds with diverse proteins in complex proteomes, as well as compositions for performing the method.Type: ApplicationFiled: August 4, 2020Publication date: September 1, 2022Inventors: Ping Cao, Yuan Yuan, Chao Zhang
-
Publication number: 20220218703Abstract: The disclosure provides novel FGFR inhibitors based on the pyridinylpyrimidine. The disclosure includes inhibitors with broad inhibitory activity against all FGFR isoforms, and inhibitors with selective inhibition against FGFR4. These novel pyridinylpyrimidine-based FGFR inhibitors, or their derivatives, have strong potential to be used to treat cancer.Type: ApplicationFiled: February 14, 2020Publication date: July 14, 2022Inventors: Ping Cao, Chao Zhang, Michael J. Bishop
-
Publication number: 20210258816Abstract: A method includes: A first device sends a first signal to a second device, where the first signal includes a first transmit signal and a first pilot signal; the first device obtains a second signal, where the second signal includes a first self-interference signal, a second pilot signal, and a second receive signal from the second device; the first device extracts jitter information of the first self-interference signal based on the first pilot signal and the second pilot signal; the first device reconstructs a self-interference signal based on the first transmit signal and the jitter information of the first self-interference signal, to obtain a cancellation signal of the first self-interference signal; and the first device cancels the first self-interference signal from the second receive signal based on the cancellation signal of the first self-interference signal.Type: ApplicationFiled: May 6, 2021Publication date: August 19, 2021Inventors: Meng CAI, Kun LI, Jiantao MA, Ping CAO, Hongli JIANG
-
Patent number: 10683333Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.Type: GrantFiled: July 11, 2018Date of Patent: June 16, 2020Assignee: The Research Foundation for The State University of New YorkInventors: Daniel Raleigh, Hui Wang, Ping Cao, Andisheh Abedini
-
Patent number: 10319728Abstract: In some examples, a fluid ejection device includes a substrate and a memory cell on the substrate, the memory cell including a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The memory cell includes a channel region between a drain region and a source region. The first dielectric layer is over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The floating gate includes a polysilicon layer, a metal layer, and a second dielectric layer between the polysilicon layer and the metal layer, where the second dielectric layer includes an opening through which the polysilicon layer is electrically connected to the metal layer.Type: GrantFiled: December 14, 2016Date of Patent: June 11, 2019Assignee: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.Inventors: Chaw Sing Ho, Reynaldo V. Villavelez, Xin Ping Cao
-
Publication number: 20180319860Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.Type: ApplicationFiled: July 11, 2018Publication date: November 8, 2018Applicant: The Research Foundation for The State University of New YorkInventors: Daniel RALEIGH, Hui WANG, Ping CAO, Andisheh ABEDINI
-
Patent number: 10072060Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.Type: GrantFiled: May 1, 2015Date of Patent: September 11, 2018Assignee: The Research Foundation for The State University of New YorkInventors: Daniel Raleigh, Hui Wang, Ping Cao, Andisheh Abedini
-
Patent number: 9813923Abstract: The present invention relates to the field of network communications, and discloses a duplex mode adaptive method, including: querying the modulation mode configuration table, to obtain a maximum modulation mode of the current duplex mode and a maximum modulation mode of the non-current duplex mode; calculating maximum spectral efficiency of the current duplex mode according to the maximum modulation mode of the current duplex mode; calculating maximum spectral efficiency of the non-current duplex mode according to the maximum modulation mode of the non-current duplex mode; comparing the maximum spectral efficiency of the current duplex mode with the maximum spectral efficiency of the non-current duplex mode, and selecting a duplex mode whose spectral efficiency is greater as a next-step duplex mode; and switching a duplex mode of the wireless communications apparatus to the next-step duplex mode.Type: GrantFiled: February 26, 2016Date of Patent: November 7, 2017Assignee: Huawei Technologies Co., Ltd.Inventors: Hongli Jiang, Huaping Qing, Ping Cao, Qiao Liu, Yu Liu
-
Publication number: 20170092653Abstract: In some examples, a fluid ejection device includes a substrate and a memory cell on the substrate, the memory cell including a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The memory cell includes a channel region between a drain region and a source region. The first dielectric layer is over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The floating gate includes a polysilicon layer, a metal layer, and a second dielectric layer between the polysilicon layer and the metal layer, where the second dielectric layer includes an opening through which the polysilicon layer is electrically connected to the metal layer.Type: ApplicationFiled: December 14, 2016Publication date: March 30, 2017Inventors: Chaw Sing Ho, Reynaldo V. Villavelez, Xin Ping Cao
-
Publication number: 20170051032Abstract: The present disclosure provides for isolated non-naturally occurring, mutant-human IAPP polypeptides. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. The present disclosure also provides methods and compositions for treating amyloid-based disease in a subject in need thereof, comprising administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof.Type: ApplicationFiled: May 1, 2015Publication date: February 23, 2017Applicant: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORKInventors: Daniel RALEIGH, Hui WANG, Ping CAO, Andisheh ABEDINI
-
Patent number: 9559106Abstract: A memory cell including a substrate, a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The substrate includes a channel region situated between a drain region and a source region. The first dielectric layer is situated over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The second dielectric layer is situated over the floating gate and the control gate is capacitively coupled to the floating gate through the second dielectric layer. A dielectric nitride layer is situated between the floating gate and the second dielectric layer to prevent charge loss from the floating gate to the second dielectric layer.Type: GrantFiled: October 31, 2012Date of Patent: January 31, 2017Assignee: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.Inventors: Chaw-Sing Ho, Reynaldo Villavelez, Xin Ping Cao
-
Publication number: 20160183105Abstract: The present invention relates to the field of network communications, and discloses a duplex mode adaptive method, including: querying the modulation mode configuration table, to obtain a maximum modulation mode of the current duplex mode and a maximum modulation mode of the non-current duplex mode; calculating maximum spectral efficiency of the current duplex mode according to the maximum modulation mode of the current duplex mode; calculating maximum spectral efficiency of the non-current duplex mode according to the maximum modulation mode of the non-current duplex mode; comparing the maximum spectral efficiency of the current duplex mode with the maximum spectral efficiency of the non-current duplex mode, and selecting a duplex mode whose spectral efficiency is greater as a next-step duplex mode; and switching a duplex mode of the wireless communications apparatus to the next-step duplex mode.Type: ApplicationFiled: February 26, 2016Publication date: June 23, 2016Inventors: Hongli Jiang, Huaping Qing, Ping Cao, Qiao Liu, Yu Liu